Avni Shah
Pediatric Endocrinology · Houston, TXNPI 1194025072
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $934, 8.7 times the $107 reported in 2019.
Across 111 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$319
- AbbVie$208
- Novo Nordisk$204
- Ascendis Pharma Endocrinology Inc$194
- Tolmar, Inc.$188
- Dexcom, Inc.$174
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,30198%
- Education$562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 9 | $319 |
| AbbVie | 11 | $208 |
| Novo Nordisk | 5 | $204 |
| Ascendis Pharma Endocrinology Inc | 10 | $194 |
| Tolmar, Inc. | 10 | $188 |
| Dexcom, Inc. | 9 | $174 |
| BETA Bionics, Inc. | 10 | $155 |
| Neurocrine Biosciences, Inc. | 7 | $154 |
| Tandem Diabetes Care, Inc. | 9 | $132 |
| Sequel Med Tech, LLC | 4 | $108 |
| Sanofi Pasteur Inc. | 4 | $88 |
| Abbott | 4 | $82 |
| Intuity Medical Inc | 3 | $53 |
| Amgen | 2 | $44 |
| Cequr Corporation | 2 | $32 |
| IBSA Pharma Inc. | 2 | $32 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| Mannkind Corporation | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sogroya$113
How this compares
$2,357 in reported general payments places this provider in the 65th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Houston
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Steven WaguespackHouston$37K
- Morey HaymondHouston$30K
- Maria RedondoHouston$19K
- Stephanie SisleyHouston$10K
- Walid KaplanHouston$4K
- Michael YafiHouston$3K
- Luisa RodriguezHouston$2K
- Luz CastellanosHouston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.